Document is current
Any future updates will be listed below
-
Authors
Kassem, Ibrahim
Van Essche, Cyril
Hoton, Delphine https://orcid.org/0000-0002-7947-4561
Dubois, Dominique https://orcid.org/0000-0001-7347-5304
Camby, Philippe
Dekairelle, Anne-France
Guiot, Yves https://orcid.org/0000-0003-4120-0204
Libbrecht, Louis https://orcid.org/0000-0002-9453-3355
Van Bockstal, Mieke R. https://orcid.org/0000-0003-4498-928X
-
Funding
Funding for this research was provided by:
Stichting Tegen Kanker (2019-089)
- License Information
-
More Information
Article History
Received: 8 August 2025
Revised: 30 October 2025
Accepted: 7 November 2025
First Online: 8 December 2025
Declarations
:
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: M.R. Van Bockstal previously received institutional research and/or travel support from Roche and Sysmex, as well as institutional consulting fees for being a member of advisory boards of AstraZeneca and Sakura, all unrelated to the present work. The other authors declare no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
